Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E19.39 EPS (ttm)2.18 Insider Own0.04% Shs Outstand5.87B Perf Week3.72%
Market Cap248.31B Forward P/E13.70 EPS next Y3.09 Insider Trans-38.34% Shs Float5.85B Perf Month13.39%
Income13.15B PEG2.77 EPS next Q0.75 Inst Own73.00% Short Float0.93% Perf Quarter18.24%
Sales53.24B P/S4.66 EPS this Y68.20% Inst Trans0.02% Short Ratio2.67 Perf Half Y17.55%
Book/sh11.89 P/B3.56 EPS next Y3.24% ROA13.40% Target Price40.80 Perf Year29.57%
Cash/sh2.29 P/C18.49 EPS next 5Y7.00% ROE33.20% 52W Range32.32 - 42.77 Perf YTD16.87%
Dividend1.36 P/FCF30.03 EPS past 5Y10.40% ROI11.00% 52W High-1.23% Beta0.95
Dividend %3.21% Quick Ratio0.90 Sales past 5Y-0.80% Gross Margin78.90% 52W Low30.71% ATR0.60
Employees90200 Current Ratio1.20 Sales Q/Q4.40% Oper. Margin25.40% RSI (14)76.93 Volatility1.40% 1.68%
OptionableYes Debt/Eq0.58 EPS Q/Q27.90% Profit Margin42.30% Rel Volume0.76 Prev Close42.33
ShortableYes LT Debt/Eq0.41 EarningsJul 31 BMO Payout34.80% Avg Volume20.49M Price42.24
Recom2.60 SMA204.96% SMA5010.72% SMA20015.51% Volume9,335,427 Change-0.20%
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Aug-21-18 10:47AM  FDA extends certain EpiPen expiration dates to combat shortage CNBC
10:06AM  Medtronic Earnings, Revenue Beat in Q1
06:02AM  Pfizer Stock Just Hit a 10-Year High: Buy, Sell, or Hold? Motley Fool
Aug-20-18 01:05PM  Drugmakers Extend Summer Rally as Markets Regain Footing Bloomberg
10:00AM  Pfizer Invites Public to View and Listen to Webcast of August 27 Conference Call with Analysts and Investors to Review Tafamidis Data Presentation at ESC Congress 2018 Business Wire
08:00AM  3 Things Alnylam's Management Wants Investors to Know About the Launch of Onpattro Motley Fool
Aug-19-18 09:02AM  Is Viking Therapeutics, Inc. a Buy? Motley Fool
Aug-17-18 10:02PM  Heres Why Alnylams Shares Are Tumbling Motley Fool
02:47PM  2 Reasons Alnylam Stock Fell on a Landmark Drug Approval Motley Fool
02:45PM  Retailer Breaks Out As This Dow Jones Stock Is A New Emerging Winner Investor's Business Daily
02:00PM  Pfizer, at Highest Price in a Decade, May Fall 10% Investopedia
12:27PM  3 Tough-Luck Tumbles in Healthcare: Are They Buys? Motley Fool
10:29AM  Lifesaving EpiPen Device Still Out of Stock at Many Pharmacies Bloomberg
10:27AM  Mylan Suffers a Blow as Teva Gets FDA Nod for EpiPen Generic Zacks
10:17AM  Company News For Aug 17, 2018 Zacks
09:01AM  EpiPen shortage has parents struggling during back-to-school season CNBC
07:31AM  If I Had to Buy 1 Stock in August, It Would Be This One Motley Fool
04:24AM  Glaxo, J&J's Dual Drug HIV Regimen Succeeds in Phase III Study Zacks
Aug-16-18 07:03PM  Cramer throws out this tech stock to diversify portfolio CNBC Videos
09:03AM  3 Terrible Reasons to Sell Pfizer Stock Motley Fool
07:46AM  Stocks making the biggest moves premarket: WMT, JD, JCP, BA, CSCO & more CNBC
07:19AM  Should Gilead Be Worried About This New Monthly HIV Medication? Motley Fool
07:00AM  [$$] Pfizer, BioNTech in $425 Million Flu Vaccine Collaboration The Wall Street Journal
01:48AM  [$$] Teva shares climb after FDA approves its generic EpiPen Financial Times
01:14AM  Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance Reuters
01:00AM  Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance Reuters
Aug-15-18 03:05PM  FANG Stocks Take Heat As Distribution Hits Nasdaq; Netflix Slumps 3.5% Investor's Business Daily
12:00PM  A Rare Genetic Aversion to Sweets Could Be Key to Fighting Obesity Bloomberg
11:53AM  Buy Stocks That Are Down, Not Up, Here
08:56AM  3 Hurdles Ahead of Alnylam and Its Revolutionary New Drug Motley Fool
06:00AM  What's Next for Spark Therapeutics Motley Fool
Aug-12-18 11:46AM  3 Beaten-Down Biotech Stocks: Can They Recover? Motley Fool
Aug-10-18 10:15PM  GlycoMimetics (GLYC) Q2 2018 Earnings Conference Call Transcript Motley Fool
03:17PM  GlycoMimetics Stock Has Substantial Upside InvestorPlace
01:25PM  Mylan (MYL) Q2 2018 Earnings Conference Call Transcript Motley Fool
12:35PM  Pharma Stocks Are Starting to Look More Attractive
10:48AM  You Better Be Careful with Merck Stock, Especially at These Highs InvestorPlace
10:33AM  In $270M Peninsula vaccine company buyout, small players look to be big shots American City Business Journals
Aug-09-18 10:25PM  Carl Icahn Fires Shots at Express Scripts Motley Fool
07:00PM  ICU Medical, Inc. (ICUI) Q2 2018 Earnings Conference Call Transcript Motley Fool
12:20PM  Why Sangamo Therapeutics, Inc. Stock Is Popping Today Motley Fool
09:31AM  Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well Zacks
Aug-08-18 05:23PM  After dismal earnings season, are we witnessing the reven... CNBC Videos
03:47PM  Mylan N.V. (MYL) Q2 2018 Earnings Conference Call Transcript Motley Fool
11:45AM  3 Top Dividend Stocks to Buy Right Now Motley Fool
11:21AM  Protagonist Stock Jumps 58% After Re-Review of Test Results InvestorPlace
10:41AM  You Might Still Have Trouble Buying an EpiPen Bloomberg
10:07AM  Cigna CEO is 'disappointed' Carl Icahn shared his concerns about Express Scripts deal in open letter CNBC
Aug-07-18 08:53PM  Trump says will make announcement next week on reducing drug prices Reuters
06:22PM  Trump administration opens up more drugs covered by Medicare to price negotiations CNBC
09:50AM  Q2 Earnings Drive Pharma ETFs Higher Zacks
09:31AM  Your first trade for Tuesday, August 7 CNBC
06:33AM  Get Paid While You Wait: 3 Top Dividend Stocks in Healthcare Motley Fool
Aug-06-18 04:14PM  Here's Why Antares Pharma Jumped Today Motley Fool
09:21AM  Why Pfizer Stock Gained 10% in July Motley Fool
09:09AM  The Zacks Analyst Blog Highlights: Pfizer, Bristol-Myers, Sanofi, Glaxo and Novartis Zacks
08:51AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Aug-05-18 09:31AM  Better Buy: Pfizer Inc. vs. AbbVie Inc. Motley Fool
Aug-03-18 06:19PM  This week's winners: 4 trades CNBC Videos
05:31PM  Trade it or fade it: This week's winners CNBC Videos
03:32PM  10 Hot Stocks to Invest In Right Now InvestorPlace
11:32AM  Health-care pharma stocks are on fire, here's how to trad... CNBC Videos
11:23AM  Pharma Stock Roundup: PFE Dominates Headlines, BMY Drug Gets EU Approval Zacks
11:05AM  BioMarin (BMRN) Q2 Earnings Miss Estimates, Revenues Beat Zacks
10:49AM  Is Pfizer (PFE) a Good Pick for Income Investors? Zacks
09:30AM  PFE vs. MRK: Which Stock Should Value Investors Buy Now? Zacks
Aug-02-18 07:42PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:48PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:16PM  Allergan sues Pfizer over costs of opioid litigation Reuters
02:31PM  Allergan Sues Pfizer Over Damages in Opioid Litigation Bloomberg
02:10PM  Moody's: US drug makers face heightened pricing pressure as regulatory risks pick up steam Moody's
01:13PM  Allergan Sues Pfizer, King Over Opioid Litigation Costs Bloomberg
09:30AM  Thursdays Vital Data: Tesla, Pfizer and MGM Resorts International InvestorPlace
06:33AM  5 Things You'll Want to Know About Pfizer's Future Motley Fool
06:32AM  Better Buy: Johnson & Johnson vs. Pfizer Motley Fool
Aug-01-18 04:12PM  Why The 'Heat Wave' For U.S. Pharma Could Continue This Month Investor's Business Daily
02:18PM  Healthcare Bulls Are Feeling Great After Earnings
10:48AM  Drug Stock Q2 Earnings Releases on Aug 2: ZTS, REGN & More Zacks
10:41AM  Stock Market News For Aug 1, 2018 Zacks
10:35AM  Edited Transcript of PFE earnings conference call or presentation 31-Jul-18 2:00pm GMT Thomson Reuters StreetEvents
09:27AM  Your first trade for Wednesday, August 1 CNBC
09:01AM  Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Heron Therapeutics and Pfizer ACCESSWIRE
07:00AM  Heres Why You Shouldnt Invest in Cryptocurrency InvestorPlace
01:00AM  XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis Business Wire
12:00AM  [$$] Trump is losing the war on drug prices Financial Times
Jul-31-18 09:31PM  Is Opko Health Getting Its Mojo Back? Motley Fool
07:44PM  [$$] Pfizer to Raise R&D Spending as Pipeline Focus Sharpens The Wall Street Journal
06:11PM  Final Trade: CBS, PFE & more CNBC Videos
05:21PM  Business Highlights Associated Press
04:41PM  KLA-Tencor and Pfizer jump; IPG and Chipotle slide Associated Press
04:20PM  Pfizer Breaks Out As CEO Mulls Future Of Drug Price Rebates Investor's Business Daily
04:05PM  Dow, Nasdaq and S&P 500 End Higher on Tech Rebound
03:49PM  Pfizer Earnings: More Blockbuster Drugs to Come?
03:15PM  Pfizer, Inc. (PFE) Q2 2018 Earnings Conference Call Transcript Motley Fool
03:01PM  7 Things You Might Have Missed With Pfizer's Q2 Earnings Results Motley Fool
02:46PM  Pfizer CEO expects Trump to eliminate drug rebates Reuters
02:42PM  Pfizer CEO believes U.S. will eliminate rebates on prescription drugs Reuters
02:27PM  Pfizer CEO expects Trump to eliminate drug rebates Reuters
02:14PM  Pfizer Rises 3.06% With Earnings In Focus
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brand names. This segment also engages in the research and development, as well as contract manufacturing activities. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company for the development of Eliquis; Astellas Pharma US, Inc. for developing Xtandi; Merck KGaA for the development of Bavencio; and Neofluidics, LLC to develop a microfluidics-based platform, as well as development agreement with Antares Pharma, Inc. to develop a combination drug device rescue pen. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
SUSMAN SALLYExecutive Vice PresidentJul 20Sale37.2240,3811,502,925115,096Jul 24 01:09 PM
READ IAN CChairman & CEOJul 16Sale37.36486,75318,186,315659,440Jul 17 04:59 PM
OLSON LAURIE JExecutive Vice PresidentJun 06Sale36.4519,000692,58282,886Jun 08 01:11 PM
CORNWELL W DONDirectorJun 04Sale36.405,223190,1170Jun 05 04:44 PM
READ IAN CChairman & CEOMay 01Sale36.01132,3124,764,0811,144,703May 03 04:19 PM
JOHNSON RADY AExecutive Vice PresidentMar 13Sale36.5527,323998,66643,178Mar 14 05:19 PM
LANKLER DOUGLAS MExecutive Vice PresidentMar 13Sale36.8950,0001,844,39883,857Mar 14 05:13 PM
Dolsten MikaelPresident R&DMar 09Sale36.5969,6992,550,39451,185Mar 12 05:01 PM
HILL CHARLES HExecutive Vice PresidentMar 06Sale35.7642,3931,515,98557,328Mar 07 04:09 PM
Dolsten MikaelPresident R&DMar 02Sale35.8513,986501,398120,884Mar 05 09:23 AM
HILL CHARLES HExecutive Vice PresidentFeb 28Option Exercise27.37101,8722,788,237207,942Mar 02 03:24 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37121,1453,315,739362,707Mar 02 04:10 PM
OLSON LAURIE JExecutive Vice PresidentFeb 28Option Exercise27.3738,5461,055,004132,702Mar 02 04:02 PM
READ IAN CChairman & CEOFeb 28Option Exercise27.37649,78017,784,4791,774,184Mar 02 04:03 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.37110,1323,014,313245,362Mar 02 04:03 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50239,801Mar 02 03:44 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50285,910Mar 02 03:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3746,8061,281,080171,276Mar 02 03:44 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 28Option Exercise27.37104,6262,863,614384,219Mar 02 03:44 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37209,2515,727,200655,161Mar 02 03:24 PM
BOURLA ALBERTChief Operating OfficerFeb 28Option Exercise27.3739,9231,092,693184,120Mar 02 03:24 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3733,040904,305136,847Mar 02 03:24 PM
Dolsten MikaelPresident R&DFeb 28Option Exercise27.37198,2385,425,774293,352Mar 02 03:24 PM
HILL CHARLES HExecutive Vice PresidentFeb 28Sale36.8326,779986,292181,163Mar 02 03:24 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Sale37.0333,3681,235,591135,230Feb 28 06:14 PM
Dolsten MikaelPresident R&DFeb 27Sale37.0464,5872,392,31395,114Feb 28 06:04 PM
CORNWELL W DONDirectorFeb 27Sale37.0530011,1150Feb 28 01:29 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 26Sale37.199,510353,67717,770Feb 27 07:38 PM
CORNWELL W DONDirectorFeb 26Sale36.741,45853,5640Feb 28 01:29 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9043,520822,528223,733Feb 27 08:59 PM
READ IAN CChairman & CEOFeb 24Option Exercise19.83903,55917,917,2651,560,007Feb 27 08:58 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9015,716297,03290,222Feb 27 07:53 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456206,972Feb 27 07:51 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9015,885300,22762,848Feb 27 07:43 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9028,288534,643112,081Feb 27 07:43 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456313,499Feb 27 07:43 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 24Option Exercise18.9015,957301,58736,959Feb 27 07:38 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 24Option Exercise18.9039,555747,590143,152Feb 27 07:38 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9065,2801,233,792122,609Feb 27 07:38 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90174,0813,290,131225,265Feb 27 07:32 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9028,288534,643116,769Feb 27 07:30 PM
BOURLA ALBERTChief Operating OfficerFeb 24Option Exercise18.9025,387479,814158,170Feb 27 07:30 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90174,0813,290,131511,470Feb 27 07:30 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 15Sale37.006,750249,750103,458Dec 18 06:17 PM
JOHNSON RADY AExecutive Vice PresidentDec 15Sale37.078,000296,56046,963Dec 18 06:17 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentNov 01Sale34.947,350256,809110,082Nov 02 07:03 PM
PFIZER INC10% OwnerOct 10Buy17.0040,000680,0001,427,639Oct 10 04:22 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentOct 02Sale35.657,350262,028117,432Nov 02 07:03 PM
SUSMAN SALLYExecutive Vice PresidentSep 12Sale35.0038,2301,338,050115,096Sep 14 09:13 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentSep 01Sale34.007,350249,900124,774Sep 05 06:15 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 31Sale34.007,350249,900132,124Sep 01 06:37 PM
DAMELIO FRANK AExecutive Vice PresidentAug 31Sale34.0094,4093,209,906337,389Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.00141,1934,800,56280,762Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.0055,9751,903,150580,318Sep 01 06:37 PM